Victory Capital Management Inc. acquired a new stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor acquired 28,190 shares of the biopharmaceutical company’s stock, valued at approximately $1,009,000. Several other large investors also recently modified their holdings of XENE. […]